类风湿性关节炎疼痛机制的研究进展
Research Progress on the Mechanisms of Pain in Rheumatoid Arthritis
DOI: 10.12677/ACM.2023.13102157, PDF,    科研立项经费支持
作者: 周士杰, 崔永辉, 沈 熙, 顾昱航, 虞正权*：苏州大学附属第一医院神经外科，江苏 苏州；温世博：苏州大学苏州医学院，江苏 苏州
关键词: 类风湿性关节炎；自身免疫性疾病；疼痛机制；细胞因子；信号转导通路；微小核糖核酸；靶向治疗；Rheumatoid Arthritis； Autoimmune Disease； Pain Mechanism； Cytokines； Signaling Pathways； microRNA； Targeted Therapy
摘要: 类风湿性关节炎是一种可引起机体关节疼痛、肿胀、畸形甚至器官损害的自身免疫性疾病。全球发病普遍，中国发病率为0.42%，全球为0.27%。除关节问题外，该疾病还会导致患者生活质量下降，严重者甚至会给社会带来沉重的经济负担。本文着眼于类风湿性关节炎引起疼痛的潜在机制，从细胞因子、信号转导途径以及微小核糖核酸三方面阐述目前类风湿性关节炎疼痛机制的研究进展，并适当结合说明此疾病的临床诊疗方法，对类风湿性关节炎未来的研究方向做出了相应的展望。
Abstract: Rheumatoid arthritis (RA) is an autoimmune disease that can cause joint pain, swelling, deformity and even organ damage. It is prevalent globally, with an incidence of 0.27% worldwide and 0.42% in China. In addition to joint problems, the disease can also lead to a decline in the quality of life of patients, and even bring a heavy economic burden to society in severe cases. The primary objective of this paper is to delve into the mechanisms responsible for the pain induced by RA. It aims to elu-cidate the current advancements in research concerning cytokines, signaling pathways, and mi-croRNAs. The article appropriately integrates clinical diagnosis and treatment methods for this condition and provides a perspective on future research directions in the field of rheumatoid ar-thritis.
文章引用：周士杰, 崔永辉, 沈熙, 顾昱航, 温世博, 虞正权. 类风湿性关节炎疼痛机制的研究进展[J]. 临床医学进展, 2023, 13(10): 15423-15434. https://doi.org/10.12677/ACM.2023.13102157

参考文献

[1] Smith, M.H. and Berman, J.R. (2022) What Is Rheumatoid Arthritis? JAMA, 327, 1194-1194. [Google Scholar] [CrossRef] [PubMed]
[2] Radu, A.F. and Bungau, S.G. (2021) Management of Rheumatoid Arthritis: An Overview. Cells, 10, Article No. 2857. [Google Scholar] [CrossRef] [PubMed]
[3] Aviña-Zubieta, J.A., Choi, H.K., Sadatsafavi, M., Etminan, M., Esdaile, J.M. and Lacaille, D. (2008) Risk of Cardiovascular Mortality in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies. Arthritis & Rheumatology, 59, 1690-1697. [Google Scholar] [CrossRef] [PubMed]
[4] Kadura, S. and Raghu, G. (2021) Rheumatoid Arthritis-Interstitial Lung Disease: Manifestations and Current Concepts in Pathogen-esis and Management. European Respiratory Review, 30, Article ID: 210011. [Google Scholar] [CrossRef] [PubMed]
[5] Finckh, A., Gilbert, B., Hodkinson, B., Bae, S.C., Thomas, R., Deane, K.D., Alpizar-Rodriguez, D. and Lauper, K. (2022) Global Epidemiology of Rheumatoid Arthritis. Nature Re-views Rheumatology, 18, 591-602. [Google Scholar] [CrossRef] [PubMed]
[6] Kawai, V.K., Shi, M., Feng, Q., Chung, C.P., Liu, G., Cox, N.J., et al. (2020) Pleiotropy in the Genetic Predisposition to Rheumatoid Arthritis: A Phenome-Wide Association Study and Inverse Variance-Weighted Meta-Analysis. Arthritis & Rheumatology, 72, 1483-1492. [Google Scholar] [CrossRef] [PubMed]
[7] Maeda, K., Yoshida, K., Nishizawa, T., Otani, K., Yamashita, Y., Okabe, H., et al. (2022) Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments. International Journal of Molecular Sciences, 23, Article No. 2871. [Google Scholar] [CrossRef] [PubMed]
[8] Kondo, N., Kuroda, T. and Kobayashi, D. (2021) Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis. International Journal of Molecular Sciences, 22, Article No. 10922. [Google Scholar] [CrossRef] [PubMed]
[9] Lopez-Castejon, G. and Brough, D. (2011) Understanding the Mecha-nism of IL-1β Secretion. Cytokine and Growth Factor Reviews, 22, 189-195. [Google Scholar] [CrossRef] [PubMed]
[10] Pein, M., Insua-Rodríguez, J., Hongu, T., Riedel, A., Meier, J., Wiedmann, L., et al. (2020) Metastasis-Initiating Cells Induce and Exploit a Fibroblast Niche to Fuel Malignant Coloni-zation of the Lungs. Nature Communications, 11, Article No. 1494. [Google Scholar] [CrossRef] [PubMed]
[11] Arima, Y., Kamimura, D., Atsumi, T., Harada, M., Kawamoto, T., Nishikawa, N., Stofkova, A., et al. (2015) A Pain- Mediated Neural Signal Induces Relapse in Murine Autoimmune Encephalomyelitis, a Multiple Sclerosis Model. Elife, 4, e08733. [Google Scholar] [CrossRef] 
[12] Mailhot, B., Christin, M., Tessandier, N., Sotoudeh, C., Bretheau, F., Turmel, R., et al. (2020) Neuronal Interleukin-1 Receptors Mediate Pain in Chronic Inflammatory Diseases. Journal of Experimental Medicine, 217, e20191430. [Google Scholar] [CrossRef] [PubMed]
[13] Karpouzas, G.A., Ormseth, S.R., Hernandez, E. and Budoff, M.J. (2020) Biologics May Prevent Cardiovascular Events in Rheumatoid Arthritis by Inhibiting Coronary Plaque Formation and Stabilizing High-Risk Lesions. Arthritis & Rheumatology, 72, 1467-1475. [Google Scholar] [CrossRef] [PubMed]
[14] Boyapati, A., Schwartzman, S., Msihid, J., Choy, E., Genovese, M.C., Burmester, G.R., et al. (2020) Association of High Serum Interleukin-6 Levels with Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab from Adalimumab or Methotrexate in a Post Hoc Analysis. Arthritis & Rheumatology, 72, 1456-1466. [Google Scholar] [CrossRef] [PubMed]
[15] Bell, R.D., Rahimi, H., Kenney, H.M., Lieberman, A.A., Wood, R.W., Schwarz, E.M. and Ritchlin, C.T. (2020) Altered Lymphatic Vessel Anatomy and Markedly Diminished Lymph Clearance in Affected Hands of Patients with Active Rheumatoid Arthritis. Arthritis & Rheumatology, 72, 1447-1455. [Google Scholar] [CrossRef] [PubMed]
[16] Atzeni, F., Nucera, V., Masala, I.F., Sarzi-Puttini, P. and Bonitta, G. (2019) Il-6 Involvement in Pain, Fatigue and Mood Disorders in Rheumatoid Ar-thritis and the Effects of Il-6 Inhibitor Sarilumab. Pharmacological Research, 149, Article ID: 104402. [Google Scholar] [CrossRef] [PubMed]
[17] Brenn, D., Richter, F. and Schaible, H.G. (2007) Sensitization of Unmyelinated Sensory Fibers of the Joint Nerve to Mechanical Stimuli by Interleukin-6 in the Rat: An Inflammatory Mechanism of Joint Pain. Arthritis & Rheumatology, 56, 351-359. [Google Scholar] [CrossRef] [PubMed]
[18] Zhou, Y.Q., Liu, Z., Liu, Z.H., Chen, S.P., Li, M., Shahveranov, A., Ye, D.W. and Tian, Y.K. (2016) Interleukin-6: An Emerging Regulator of Pathological Pain. Journal of Neuroinflammation, 13, Article No. 141. [Google Scholar] [CrossRef] [PubMed]
[19] Onuora, S. (2022) Calprotectin Tracks Tocilizumab-Treated RA. Nature Reviews Rheumatology, 18, Article No. 612. [Google Scholar] [CrossRef] [PubMed]
[20] Giles, J.T., Sattar, N., Gabriel, S., Ridker, P.M., Gay, S., Warne, C., et al. (2020) Cardiovascular Safety of Tocilizumab versus Etanercept in Rheumatoid Arthritis: A Randomized Con-trolled Trial. Arthritis & Rheumatology, 72, 31-40. [Google Scholar] [CrossRef] [PubMed]
[21] Yi, X.M., Li, M., Chen, Y.D., Shu, H.B. and Li, S. (2022) Reciprocal Reg-ulation of IL-33 Receptor-Mediated Inflammatory Response and Pulmonary Fibrosis by TRAF6 and USP38. Proceed-ings of the National Academy of Sciences of the United States of America, 119, e2116279119. [Google Scholar] [CrossRef] [PubMed]
[22] Yuan, C. (2022) IL-33 in Autoimmunity, Possible Therapeutic Tar-get. International Immunopharmacology, 108, Article ID: 108887. [Google Scholar] [CrossRef] [PubMed]
[23] Wu, S., Jiang, Y., Teng, Y., Liu, X., Zhou, L. and Li, W. (2021) Interleukin-33 Promotes Proliferation and Inhibits Apoptosis of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis. Clinical and Experimental Rheumatology, 39, 844- 851. [Google Scholar] [CrossRef] [PubMed]
[24] Iwaszko, M., Wielińska, J., Świerkot, J., Kolossa, K., Sokolik, R., Bugaj, B., et al. (2021) IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients. Frontiers in Immunology, 12, Article ID: 631603. [Google Scholar] [CrossRef] [PubMed]
[25] Ruiz de Morales, J.M.G., Puig, L., Daudén, E., Cañete, J.D., Pablos, J.L., Martín, A.O., et al. (2020) Critical Role of Interleukin (IL)-17 in Inflammatory and Immune Disorders: An Updated Review of the Evidence Focusing in Controversies. Autoimmunity Reviews, 19, Article ID: 102429. [Google Scholar] [CrossRef] [PubMed]
[26] Du, J., Zheng, L., Chen, S., Wang, N., Pu, X., Yu, D., et al. (2022) NFIL3 and Its Immunoregulatory Role in Rheumatoid Arthritis Patients. Frontiers in Immunology, 13, Article ID: 950144. [Google Scholar] [CrossRef] [PubMed]
[27] Adib, M., Taghadosi, M., Tahmasebi, M.N., Sharafat Vaziri, A., Jamshidi, A., Mahmoudi, M. and Farhadi, E. (2023) Anti-Inflammatory Effects of PRIMA-1MET (Mutant p53 Reactivator) Induced by Inhibition of Nuclear Factor-κB on Rheumatoid Arthritis Fibroblast-Like Synoviocytes. Inflam-mopharmacology, 31, 385-394. [Google Scholar] [CrossRef] [PubMed]
[28] Taams, L.S. (2020) Interleukin-17 in Rheumatoid Arthritis: Tri-als and Tribulations. Journal of Experimental Medicine, 217, e20192048. [Google Scholar] [CrossRef] [PubMed]
[29] Chen, Z., Fan, R., Liang, J., Xiao, Z., Dang, J., Zhao, J., et al. (2022) NFIL3 Deficiency Alleviates EAE through Regulating Different Immune Cell Subsets. Journal of Advanced Research, 39, 225-235. [Google Scholar] [CrossRef] [PubMed]
[30] Yang, W., Li, J., Zhang, M., Yu, H., Zhuang, Y., Zhao, L., et al. (2022) Elevated Expression of the Rhythm Gene NFIL3 Promotes the Progression of TNBC by Activating NF-κB Sig-naling through Suppression of NFKBIA Transcription. Journal of Experimental & Clinical Cancer Research, 41, Article No. 67. [Google Scholar] [CrossRef] [PubMed]
[31] Sorokin, A.V. and Mehta, N.N. (2022) The Relationship be-tween TNF-Alpha Driven Inflammation, Lipids, and Endothelial Function in Rheumatoid Arthritis: A Complex Puzzle Continues. Cardiovascular Research, 118, 10-12. [Google Scholar] [CrossRef] [PubMed]
[32] Akram, M., Daniyal, M., Sultana, S., Owais, A., Akhtar, N., Zahid, R., et al. (2021) Traditional and Modern Management Strategies for Rheumatoid Arthritis. Clinica Chimica Acta, 512, 142-155. [Google Scholar] [CrossRef] [PubMed]
[33] Noda, K., Tajima, M., Oto, Y., Saitou, M., Yoshiga, M., Otani, K., Yoshida, K. and Kurosaka, D. (2020) How Do Neuropathic Pain-Like Symptoms Affect Health-Related Quality of Life among Patients with Rheumatoid Arthritis? A Comparison of Multiple Pain-Related Parameters. Modern Rheumatology, 30, 828-834. [Google Scholar] [CrossRef] [PubMed]
[34] Yokota, K., Sato, K., Miyazaki, T., Aizaki, Y., Tanaka, S., Sekikawa, M., et al. (2021) Characterization and Function of Tumor Necrosis Factor and Interleukin-6-Induced Osteo-clasts in Rheumatoid Arthritis. Arthritis & Rheumatology, 73, 1145-1154. [Google Scholar] [CrossRef] [PubMed]
[35] Siegel, R.J., Singh, A.K., Panipinto, P.M., Shaikh, F.S., Vinh, J., Han, S.U., et al. (2022) Extracellular Sulfatase-2 Is Overexpressed in Rheumatoid Arthritis and Mediates the TNF-α-Induced In-flammatory Activation of Synovial Fibroblasts. Cellular & Molecular Immunology, 19, 1185-1195. [Google Scholar] [CrossRef] [PubMed]
[36] Chaabo, K. and Kirkham, B. (2015) Rheumatoid Arthri-tis—Anti-TNF. International Immunopharmacology, 27, 180-184. [Google Scholar] [CrossRef] [PubMed]
[37] Lauper, K., Iudici, M., Mongin, D., Bergstra, S.A., Choquette, D., Codreanu, C., et al. (2022) Effectiveness of TNF- Inhibitors, Abatacept, IL6-Inhibitors and JAK-Inhibitors in 31 846 Pa-tients with Rheumatoid Arthritis in 19 Registers from the “JAK-Pot” Collaboration. Annals of the Rheumatic Diseases, 81, 1358-1366. [Google Scholar] [CrossRef] [PubMed]
[38] Kalden, J.R. and Schulze-Koops, H. (2017) Immunogenic-ity and Loss of Response to TNF Inhibitors: Implications for Rheumatoid Arthritis Treatment. Nature Reviews Rheuma-tology, 13, 707-718. [Google Scholar] [CrossRef] [PubMed]
[39] Zufferey, P., Perreau, M. and So, A. (2015) High Level of An-ti-Drug Antibodies after Intra-Articular Injection of Anti-TNF. Rheumatology (Oxford), 54, 2291-2292. [Google Scholar] [CrossRef] [PubMed]
[40] de Almeida, L.G.N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D., Gill, S., Devel, L. and Dufour, A. (2022) Matrix Metalloproteinases: From Molecular Mechanisms to Physi-ology, Pathophysiology, and Pharmacology. Pharmacological Reviews, 74, 712-768. [Google Scholar] [CrossRef] [PubMed]
[41] Alamgeer, Hasan, U.H., Uttra, A.M., Qasim, S., Ikram, J., Saleem, M. and Niazi, Z.R. (2020) Phytochemicals Targeting Matrix Metalloproteinases Regulating Tissue Degradation in Inflammation and Rheumatoid Arthritis. Phytomedicine, 66, Article ID: 153134. [Google Scholar] [CrossRef] [PubMed]
[42] Laronha, H. and Caldeira, J. (2020) Structure and Function of Human Matrix Metalloproteinases. Cells, 9, Article No. 1076. [Google Scholar] [CrossRef] [PubMed]
[43] Mehana, E.E., Khafaga, A.F. and El-Blehi, S.S. (2019) The Role of Matrix Metalloproteinases in Osteoarthritis Pathogenesis: An Updated Review. Life Sciences, 234, Article ID: 116786. [Google Scholar] [CrossRef] [PubMed]
[44] Zhang, H., Cai, D. and Bai, X. (2020) Macrophages Regulate the Progression of Osteoarthritis. Osteoarthritis Cartilage, 28, 555-561. [Google Scholar] [CrossRef] [PubMed]
[45] Mahmoud, R.K., El-Ansary, A.K., El-Eishi, H.H., Kamal, H.M. and El-Saeed, N.H. (2005) Matrix Metalloproteinases MMP-3 and MMP-1 Levels in Sera and Synovial Fluids in Patients with Rheumatoid Arthritis and Osteoarthritis. Italian Journal of Biochemistry, 54, 248-257.
[46] Hu, Q. and Ecker, M. (2021) Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis. International Journal of Molecular Sciences, 22, Article No. 1742. [Google Scholar] [CrossRef] [PubMed]
[47] Malemud, C.J. (2017) Matrix Metalloproteinases and Synovial Joint Pathology. Progress in Molecular Biology and Trans- lational Science, 148, 305-325. [Google Scholar] [CrossRef] [PubMed]
[48] Liu, H., Zhu, Y., Gao, Y., Qi, D., Zhao, L., Zhao, L., et al. (2020) NR1D1 Modulates Synovial Inflammation and Bone Destruction in Rheumatoid Arthritis. Cell Death & Disease, 11, Article No. 129. [Google Scholar] [CrossRef] [PubMed]
[49] Yilmaz, D., Niskanen, K., Gonullu, E., Tervahartiala, T., Gürsoy, U.K. and Sorsa, T. (2023) Salivary and Serum Levels of Neutrophil Proteases in Periodontitis and Rheumatoid Arthritis. Oral Diseases. [Google Scholar] [CrossRef] [PubMed]
[50] Raeeszadeh-Sarmazdeh, M., Do, L.D. and Hritz, B.G. (2020) Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics. Cells, 9, Article No. 1313. [Google Scholar] [CrossRef] [PubMed]
[51] Zhang, Y., Liu, J., Wang, C., Liu, J. and Lu, W. (2021) Toll-Like Re-ceptors Gene Polymorphisms in Autoimmune Disease. Frontiers in Immunology, 12, Article ID: 672346. [Google Scholar] [CrossRef] [PubMed]
[52] Wang, Y.J., Zhong, X.Y., Wang, X.H., Zhong, Y.H., Liu, L., Liu, F.Y., et al. (2022) Activity of Codonopsiscanescens against Rheumatoid Arthritis Based on TLRs/MAPKs/NF-κB Sig-naling Pathways and Its Mechanism. China Journal of Chinese Materia Medica, 47, 6164-6174.
[53] Lin, Y.J., Anzaghe, M. and Schülke, S. (2020) Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells, 9, Article No. 880. [Google Scholar] [CrossRef] [PubMed]
[54] Arleevskaya, M.I., Larionova, R.V., Brooks, W.H., Bettacchioli, E. and Renaudineau, Y. (2020) Toll-Like Receptors, Infections, and Rheumatoid Arthritis. Clinical Reviews in Allergy & Immunology, 58, 172-181. [Google Scholar] [CrossRef] [PubMed]
[55] Emami, J. and Ansarypour, Z. (2019) Receptor Targeting Drug Delivery Strategies and Prospects in the Treatment of Rheumatoid Arthritis. Research in Pharmaceutical Sciences, 14, 471-487. [Google Scholar] [CrossRef] [PubMed]
[56] Maeda, K., Kobayashi, Y., Koide, M., Uehara, S., Oka-moto, M., Ishihara, A., Kayama, T., Saito, M. and Marumo, K. (2019) The Regulation of Bone Metabolism and Disor-ders by Wnt Signaling. International Journal of Molecular Sciences, 20, Article No. 5525. [Google Scholar] [CrossRef] [PubMed]
[57] Kobayashi, Y., Uehara, S., Udagawa, N. and Takahashi, N. (2016) Featured: Regulation of Bone Metabolism by Wnt Signals. Journal of Biochemistry, 159, 387-392. [Google Scholar] [CrossRef] [PubMed]
[58] Weivoda, M.M., Ruan, M., Hachfeld, C.M., Pederson, L., Howe, A., Davey, R.A., et al. (2019) Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways. Journal of Bone and Mineral Research, 34, 1546-1548. [Google Scholar] [CrossRef] [PubMed]
[59] McLornan, D.P., Pope, J.E., Gotlib, J. and Harrison, C.N. (2021) Current and Future Status of JAK Inhibitors. The Lancet, 398, 803-816. [Google Scholar] [CrossRef] 
[60] Angelini, J., Talotta, R., Roncato, R., Fornasier, G., Barbiero, G., Dal Cin, L., Brancati, S. and Scaglione, F. (2020) JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future. Biomolecules, 10, Article No. 1002. [Google Scholar] [CrossRef] [PubMed]
[61] Crispino, N. and Ciccia, F. (2021) JAK/STAT Pathway and Nocicep-tive Cytokine Signalling in Rheumatoid Arthritis and Psoriatic Arthritis. Clinical and Experimental Rheumatology, 39, 668-675. [Google Scholar] [CrossRef] [PubMed]
[62] McInnes, I.B. and Schett, G. (2017) Pathogenetic Insights from the Treatment of Rheumatoid Arthritis. The Lancet, 389, 2328-2337. [Google Scholar] [CrossRef] 
[63] Simon, L.S., Taylor, P.C., Choy, E.H., Sebba, A., Quebe, A., Knopp, K.L. and Porreca, F. (2021) The Jak/STAT Pathway: A Focus on Pain in Rheumatoid Arthritis. Seminars in Ar-thritis and Rheumatism, 51, 278-284. [Google Scholar] [CrossRef] [PubMed]
[64] Cunningham, C.C., Wade, S., Floudas, A., Orr, C., McGarry, T., Wade, S., et al. (2021) Serum miRNA Signature in Rheu- matoid Arthritis and “At-Risk Individuals”. Frontiers in Immunology, 12, Article ID: 633201. [Google Scholar] [CrossRef] [PubMed]
[65] Saliminejad, K., Khorram Khorshid, H.R., Soleymani Fard, S. and Ghaffari, S.H. (2019) An Overview of microRNAs: Biology, Functions, Therapeutics, and Analysis Methods. Journal of Cellular Physiology, 234, 5451-5465. [Google Scholar] [CrossRef] [PubMed]
[66] Green, D., Dalmay, T. and Chapman, T. (2016) Microguards and Mi-cromessengers of the Genome. Heredity (Edinb), 116, 125-134. [Google Scholar] [CrossRef] [PubMed]
[67] Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. (2008) Characterization of microRNAs in Serum: A Novel Class of Biomarkers for Diagnosis of Cancer and Other Diseases. Cell Research, 18, 997-1006. [Google Scholar] [CrossRef] [PubMed]
[68] Reyes-Long, S., Cortes-Altamirano, J.L., Clavijio-Cornejo, D., Gutiérrez, M., Bertolazzi, C., Bandala, C., Pineda, C. and Alfaro-Rodríguez, A. (2020) Nociceptive Related microRNAs and Their Role in Rheumatoid Arthritis. Molecular Biology Reports, 47, 7265-7272. [Google Scholar] [CrossRef] [PubMed]
[69] Tsuda, S., Sameshima, A., Sekine, M., Kawaguchi, H., Fujita, D., Makino, S., et al. (2020) Pre-Conception Status, Obstetric Outcome and Use of Medications during Pregnancy of Sys-temic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA) and Inflammatory Bowel Disease (IBD) in Japan: Mul-ti-Center Retrospective Descriptive Study. Modern Rheumatology, 30, 852-861. [Google Scholar] [CrossRef] [PubMed]
[70] Qin, Y., Cai, M.L., Jin, H.Z., Huang, W., Zhu, C., Bozec, A., Huang, J. and Chen, Z. (2022) Age-Associated B Cells Contribute to the Pathogenesis of Rheumatoid Arthritis by In-ducing Activation of Fibroblast-Like Synoviocytes via TNF-α-Mediated ERK1/2 and JAK-STAT1 Pathways. Annals of the Rheumatic Diseases, 81, 1504-1514. [Google Scholar] [CrossRef] [PubMed]
[71] Burmester, G.R. and Pope, J.E. (2017) Novel Treatment Strategies in Rheumatoid Arthritis. The Lancet, 389, 2338- 2348. [Google Scholar] [CrossRef] 
[72] Gravallese, E.M. and Firestein, G.S. (2023) Rheumatoid Ar-thritis—Common Origins, Divergent Mechanisms. The New England Journal of Medicine, 388, 529-542. [Google Scholar] [CrossRef] 
[73] Huang, J., Fu, X., Chen, X., Li, Z., Huang, Y. and Liang, C. (2021) Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. Frontiers in Immunology, 12, Article ID: 686155. [Google Scholar] [CrossRef] [PubMed]
[74] Littlejohn, E.A. and Monrad, S.U. (2018) Early Diagnosis and Treatment of Rheumatoid Arthritis. Prim Care, 45, 237- 255. [Google Scholar] [CrossRef] [PubMed]
[75] Bhamidipati, K. and Wei, K. (2022) Precision Medicine in Rheu-matoid Arthritis. Best Practice & Research: Clinical Rheumatology, 36, Article ID: 101742. [Google Scholar] [CrossRef] [PubMed]

为你推荐